ALNYLAM PHARMACEUTICALS, INC. Operating Cash Flow 2008-2025 | ALNY
Beta
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is ALNYLAM PHARMACEUTICALS, INC.'s current operating cash flow?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual operating cash flow for 2025 was $524.1M, a 6405.10% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. operating cash flow for the quarter ending December 31, 2025 was $163.6M.
What was ALNYLAM PHARMACEUTICALS, INC.'s operating cash flow in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual operating cash flow for 2024 was $-8.3M, a 107.98% decline from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s operating cash flow in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual operating cash flow for 2023 was $104.2M, a 119.24% increase from 2022.
Operating Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-615.0M
→
FY2025
$524.1M
080910111213141516171819202122232425
5 years selected
Operating Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $524.1M | +6405.1% | 10-K |
| FY2024 | $-8.3M | -108.0% | 10-K |
| FY2023 | $104.2M | +119.2% | 10-K |
| FY2022 | $-541.3M | +15.6% | 10-K |
| FY2021 | $-641.7M | -4.3% | 10-K |
| FY2020 | $-615.0M | -120.9% | 10-K |
| FY2019 | $-278.4M | +50.5% | 10-K |
| FY2018 | $-562.6M | -47.0% | 10-K |
| FY2017 | $-382.8M | -24.4% | 10-K |
| FY2016 | $-307.7M | -62.7% | 10-K |
| FY2015 | $-189.1M | -14.2% | 10-K |
| FY2014 | $-165.6M | -141.3% | 10-K |
| FY2013 | $-68.7M | +40.6% | 10-K |
| FY2012 | $-115.6M | -32.8% | 10-K |
| FY2011 | $-87.1M | -3.2% | 10-K |
| FY2010 | $-84.3M | -16.9% | 10-K |
| FY2009 | $-72.1M | -210.2% | 10-K |
| FY2008 | $65.5M | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →